Answers are grounded in this paper and cite their sources.
gene editing were confirmed in vivo. Controlled release of CRISPR-Cas9 RNP and codelivery with Ce6 using stimuli-responsive nanoparticles represent a versatile strategy for gene editing with potentially synergistic drug effects.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: